Related Experiment Video
Updated: Aug 16, 2026

Rapid Synthesis and Screening of Chemically Activated Transcription Factors with GFP-based Reporters
Published on: November 26, 2013
Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based
R V Abruzzese1, D Godin, V Mehta
1Valentis, Inc, The Woodlands, Texas, 77381, USA.
Abstract:
We investigated the ability of an improved mifepristone-dependent GeneSwitch system to regulate the expression of genes for two therapeutic proteins: vascular endothelial growth factor (VEGF) and erythropoietin. The GeneSwitch system consisted of two plasmids, one encoding the chimeric GeneSwitch protein, the other an inducible transgene. When the constitutive CMV promoter of the GeneSwitch plasmid was replaced by an autoinducible promoter consisting of four copies of GAL4 DNA binding sites linked to a minimal thymidine kinase promoter, the tightness of transgene regulation was improved by an order of magnitude. Quantitative RT-PCR analysis of GeneSwitch mRNA confirmed that the autoinducible promoter was responsive to mifepristone. We demonstrated the ability of the improved GeneSwitch system to regulate the expression of VEGF or erythropoietin in a biologically relevant manner after delivery of plasmids to the hind-limb muscle of adult mice. This ability of the autoinducible GeneSwitch system to regulate the expression of therapeutic proteins in mice indicates its potential for use in human gene therapy applications.
More Related Videos
Related Concept Videos
Cell Specific Gene Expression
Reporter Genes
Commonly used reporter...
Regulation of Angiogenesis and Blood Supply
Constitutive and Regulated Gene Expression

